Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England

BACKGROUND: Contradicting assumptions have been made about the effectiveness of SARS-CoV-2 vaccines in patients with multiple sclerosis (MS) receiving immunomodulatory disease-modifying therapies (DMTs) based on the quantification of humoral and cellular immune responses. This study aimed to underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Garjani, Afagh, Patel, Sameer, Bharkhada, Dhiren, Rashid, Waqar, Coles, Alasdair, Law, Graham R, Evangelou, Nikos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645279/
https://www.ncbi.nlm.nih.gov/pubmed/34896876
http://dx.doi.org/10.1016/j.msard.2021.103458

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645279/
https://www.ncbi.nlm.nih.gov/pubmed/34896876
http://dx.doi.org/10.1016/j.msard.2021.103458

Ejemplares similares